
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1146 | 1033 | 1262 | 1187 | 1525 | 1967 |
Fund Return | 14.58% | 3.29% | 26.24% | 5.88% | 8.8% | 7% |
Place in category | 555 | 621 | 565 | 351 | 464 | 369 |
% in Category | 91 | 98 | 92 | 64 | 86 | 92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Emerging Markets Equity I | 3.01B | 1.53 | 2.30 | 4.09 | ||
RBC SMID Cap Growth Fund Class I | 111.74M | 13.48 | 5.13 | 10.56 | ||
RBC Microcap Value I | 100.7M | 17.89 | 8.96 | 9.00 | ||
RBC Emerging Markets Equity Fund Cl | 103.56M | 8.46 | 2.31 | 3.98 | ||
RBC Small Cap Core I | 26.61M | 16.94 | 6.54 | 7.02 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Small Cap Index Adm | 55.54B | -1.14 | 5.79 | 8.59 | ||
Fidelity Small Cap Index Instl Pre | 25.76B | -2.85 | 3.49 | 7.38 | ||
Vanguard Small Cap Index I | 21.96B | -1.13 | 5.81 | 8.60 | ||
DFA US Small Cap I | 15.04B | -1.96 | 5.79 | 8.33 | ||
Vanguard Small Cap Index InstlPlus | 12.31B | -1.13 | 5.81 | 8.61 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Lantheus Holdings Inc | US5165441032 | 3.63 | 104.62 | -4.90% | |
Astrana Health | US03763A2078 | 3.49 | 28.20 | -2.12% | |
SPDR S&P Biotech | US78464A8707 | 3.33 | 86.17 | -0.08% | |
UFP | US9026731029 | 3.04 | 214.47 | -2.14% | |
Ducommun | US2641471097 | 2.92 | 58.97 | +1.65% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review